NFKB1 and Alzheimer disease: Hence, RIPK1-mediated inflammatory response could potentially trigger the NF-κB signaling boosting the release of pro-inflammatory cytokines which consequently aggravates the pathogenesis of AD via a malicious loop of inflammation.